Literature DB >> 29890189

Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Whan B Kim1, Brandon Worley1, James Holmes2, Elizabeth J Phillips3, Jennifer Beecker4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29890189      PMCID： PMC6234072          DOI： 10.1016/j.jaad.2018.06.002

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Peggy Sekula; Ariane Dunant; Maja Mockenhaupt; Luigi Naldi; Jan Nico Bouwes Bavinck; Sima Halevy; Sylvia Kardaun; Alexis Sidoroff; Yvonne Liss; Martin Schumacher; Jean-Claude Roujeau
Journal:  J Invest Dermatol       Date:  2013-02-07       Impact factor: 8.551
  1 in total
  3 in total

Review 1.  Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Allison S Dobry; Sonia Himed; Margo Waters; Benjamin H Kaffenberger
Journal:  Front Med (Lausanne)       Date:  2022-06-16

2.  Powering Bias and Clinically Important Treatment Effects in Randomized Trials of Critical Illness.

Authors:  Darryl Abrams; Sydney B Montesi; Sarah K L Moore; Daniel K Manson; Kaitlin M Klipper; Meredith A Case; Daniel Brodie; Jeremy R Beitler
Journal:  Crit Care Med       Date:  2020-12       Impact factor: 9.296

3.  Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.

Authors:  Rannakoe J Lehloenya
Journal:  Front Med (Lausanne)       Date:  2022-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.